• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新构建代谢与 NLRP3 炎性小体之间的联系:治疗机会。

Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities.

机构信息

Department of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Spain.

Ramón y Cajal Institute of Sanitary Research (IRYCIS), Madrid, Spain.

出版信息

Front Immunol. 2023 Jul 20;14:1232629. doi: 10.3389/fimmu.2023.1232629. eCollection 2023.

DOI:10.3389/fimmu.2023.1232629
PMID:37545507
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10402745/
Abstract

Inflammasomes are multiprotein signaling platforms in the cytosol that senses exogenous and endogenous danger signals and respond with the maturation and secretion of IL-1β and IL-18 and pyroptosis to induce inflammation and protect the host. The inflammasome best studied is the Nucleotide-binding oligomerization domain, leucine-rich repeat-containing family pyrin domain containing 3 (NLRP3) inflammasome. It is activated in a two-step process: the priming and the activation, leading to sensor NLRP3 oligomerization and recruitment of both adaptor ASC and executioner pro-caspase 1, which is activated by cleavage. Moreover, NLRP3 inflammasome activation is regulated by posttranslational modifications, including ubiquitination/deubiquitination, phosphorylation/dephosphorylation, acetylation/deacetylation, SUMOylation and nitrosylation, and interaction with NLPR3 protein binding partners. Moreover, the connection between it and metabolism is receiving increasing attention in this field. In this review, we present the structure, functions, activation, and regulation of NLRP3, with special emphasis on regulation by mitochondrial dysfunction-mtROS production and metabolic signals, i.e., metabolites as well as enzymes. By understanding the regulation of NLRP3 inflammasome activation, specific inhibitors can be rationally designed for the treatment and prevention of various immune- or metabolic-based diseases. Lastly, we review current NLRP3 inflammasome inhibitors and their mechanism of action.

摘要

炎症小体是细胞溶质中的多蛋白信号平台,可感知外源性和内源性危险信号,并通过成熟和分泌白细胞介素-1β(IL-1β)和白细胞介素-18(IL-18)以及细胞焦亡做出反应,从而引发炎症并保护宿主。研究最深入的炎症小体是核苷酸结合寡聚化结构域、富含亮氨酸重复序列的家族 pyrin 结构域包含 3(NLRP3)炎症小体。它通过两步激活:引发和激活,导致传感器 NLRP3 寡聚化,并招募衔接蛋白 ASC 和执行 pro-caspase 1,后者通过切割被激活。此外,NLRP3 炎症小体的激活受到翻译后修饰的调节,包括泛素化/去泛素化、磷酸化/去磷酸化、乙酰化/去乙酰化、SUMO 化和亚硝基化,以及与 NLRP3 蛋白结合伙伴的相互作用。此外,它与代谢之间的联系在该领域越来越受到关注。在这篇综述中,我们介绍了 NLRP3 的结构、功能、激活和调节,特别强调了线粒体功能障碍-mtROS 产生和代谢信号(即代谢物以及酶)的调节。通过了解 NLRP3 炎症小体激活的调节,可以合理设计针对各种免疫或代谢相关疾病的治疗和预防的特异性抑制剂。最后,我们综述了当前的 NLRP3 炎症小体抑制剂及其作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10402745/0b07e6439e49/fimmu-14-1232629-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10402745/5ec35892586e/fimmu-14-1232629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10402745/0b07e6439e49/fimmu-14-1232629-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10402745/5ec35892586e/fimmu-14-1232629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b17/10402745/0b07e6439e49/fimmu-14-1232629-g002.jpg

相似文献

1
Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities.重新构建代谢与 NLRP3 炎性小体之间的联系:治疗机会。
Front Immunol. 2023 Jul 20;14:1232629. doi: 10.3389/fimmu.2023.1232629. eCollection 2023.
2
New Insights on the Potential Role of Pyroptosis in Parkinson's Neuropathology and Therapeutic Targeting of NLRP3 Inflammasome with Recent Advances in Nanoparticle-Based miRNA Therapeutics.焦亡在帕金森神经病理学中的潜在作用及基于纳米颗粒的miRNA治疗学最新进展对NLRP3炎性小体的治疗靶向的新见解
Mol Neurobiol. 2025 Mar 18. doi: 10.1007/s12035-025-04818-4.
3
p120-Catenin suppresses NLRP3 inflammasome activation in macrophages.p120-连环蛋白抑制巨噬细胞中的 NLRP3 炎性小体激活。
Am J Physiol Lung Cell Mol Physiol. 2023 May 1;324(5):L596-L608. doi: 10.1152/ajplung.00328.2022. Epub 2023 Mar 7.
4
FCV activates NLRP3 inflammasome through ion-dependent pathway to promote IL-1β secretion.猫杯状病毒通过离子依赖途径激活NLRP3炎性小体以促进白细胞介素-1β的分泌。
Vet Microbiol. 2025 Aug;307:110628. doi: 10.1016/j.vetmic.2025.110628. Epub 2025 Jun 28.
5
Pepsin-mediated inflammation in laryngopharyngeal reflux via the ROS/NLRP3/IL-1β signaling pathway.胃蛋白酶介导体液反流相关性喉咽反流中通过 ROS/NLRP3/IL-1β 信号通路引发的炎症反应。
Cytokine. 2024 Jun;178:156568. doi: 10.1016/j.cyto.2024.156568. Epub 2024 Mar 11.
6
Innate immune sensor NLRP3 drives PANoptosome formation and PANoptosis.先天性免疫传感器NLRP3驱动PAN小体形成和PAN凋亡。
J Immunol. 2025 Apr 18. doi: 10.1093/jimmun/vkaf042.
7
Multiwalled carbon nanotubes activate the NLRP3 inflammasome-dependent pyroptosis in macrophages.多壁碳纳米管激活巨噬细胞中NLRP3炎性小体依赖性细胞焦亡。
Mol Pharmacol. 2025 May;107(5):100031. doi: 10.1016/j.molpha.2025.100031. Epub 2025 Apr 2.
8
Resveratrol derivative SH-707 inhibits NLRP3 inflammasome activation via a sirtuin 1-dependent pathway.白藜芦醇衍生物SH-707通过依赖沉默调节蛋白1的途径抑制NLRP3炎性小体激活。
Int Immunopharmacol. 2025 Aug 28;161:115049. doi: 10.1016/j.intimp.2025.115049. Epub 2025 Jun 15.
9
GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3.GITR 通过对 NLRP3 的翻译后调控加剧脂多糖诱导的巨噬细胞焦亡。
Cell Mol Immunol. 2024 Jul;21(7):674-688. doi: 10.1038/s41423-024-01170-w. Epub 2024 May 13.
10
The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation.MCC950 抑制 NLRP3 炎性小体对 LPS 诱导的胰腺腺癌细胞炎症的影响。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2219-2229. doi: 10.1007/s00432-020-03274-y. Epub 2020 Jun 7.

引用本文的文献

1
Microglial pyroptosis in neurological disorders: mechanistic crosstalk, metabolic triggers, and therapeutic frontiers.神经疾病中的小胶质细胞焦亡:机制串扰、代谢触发因素及治疗前沿
Metab Brain Dis. 2025 Aug 29;40(7):251. doi: 10.1007/s11011-025-01685-9.
2
The Inflammatory Bridge Between Type 2 Diabetes and Neurodegeneration: A Molecular Perspective.2型糖尿病与神经退行性变之间的炎症桥梁:分子视角
Int J Mol Sci. 2025 Aug 5;26(15):7566. doi: 10.3390/ijms26157566.
3
Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging.

本文引用的文献

1
Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3.胰腺癌患者生存率降低可能与炎症小体标志物 NLRP3 的组织病理学表达增加有关。
Histol Histopathol. 2024 Jan;39(1):35-40. doi: 10.14670/HH-18-617. Epub 2023 Apr 4.
2
The Role of Post-Translational Modifications in Regulation of NLRP3 Inflammasome Activation.翻译:翻译后修饰在调控 NLRP3 炎性小体激活中的作用。
Int J Mol Sci. 2023 Mar 24;24(7):6126. doi: 10.3390/ijms24076126.
3
Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis.
免疫代谢与氧化应激:在癌症和衰老中的作用及治疗策略
NPJ Aging. 2025 Jul 1;11(1):59. doi: 10.1038/s41514-025-00250-z.
4
Qilian Jiechang Ning Alleviates TNBS-Induced Ulcerative Colitis in Mice and Segatella copri Outer Membrane Vesicle-Triggered Inflammation in Colon Epithelial Cells via the Caspase-1/11-GSDMD Pathways.祁连节肠宁通过半胱天冬酶-1/11- Gasdermin D途径减轻三硝基苯磺酸诱导的小鼠溃疡性结肠炎及共生粪杆菌外膜囊泡引发的结肠上皮细胞炎症。
J Innate Immun. 2025;17(1):262-276. doi: 10.1159/000545394. Epub 2025 May 14.
5
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research.解读小胶质细胞免疫代谢:阿尔茨海默病研究的新前沿
Mol Neurodegener. 2025 Mar 27;20(1):37. doi: 10.1186/s13024-025-00825-0.
6
Evidence of Inflammatory Network Disruption in Chronic Venous Disease: An Analysis of Circulating Cytokines and Chemokines.慢性静脉疾病中炎症网络破坏的证据:循环细胞因子和趋化因子的分析
Biomedicines. 2025 Jan 9;13(1):150. doi: 10.3390/biomedicines13010150.
7
Identification of new tissue markers for the monitoring and standardization of penile cancer according to the degree of differentiation.根据分化程度鉴定用于阴茎癌监测和标准化的新组织标志物。
Histol Histopathol. 2025 Jul;40(7):1013-1039. doi: 10.14670/HH-18-846. Epub 2024 Nov 7.
8
Improving understanding of ferroptosis: Molecular mechanisms, connection with cellular senescence and implications for aging.增进对铁死亡的理解:分子机制、与细胞衰老的联系及对衰老的影响
Heliyon. 2024 Oct 24;10(21):e39684. doi: 10.1016/j.heliyon.2024.e39684. eCollection 2024 Nov 15.
9
Harnessing the Anti-Inflammatory Properties of Polyphenols in the Treatment of Inflammatory Bowel Disease.利用多酚的抗炎特性治疗炎症性肠病。
Int J Biol Sci. 2024 Oct 14;20(14):5608-5672. doi: 10.7150/ijbs.98107. eCollection 2024.
10
Therapeutic potential of vitamin D3 in mitigating high glucose‑induced renal damage: Mechanistic insights into oxidative stress inhibition and TXNIP/NLRP3 signaling pathway blockade.维生素D3在减轻高糖诱导的肾损伤中的治疗潜力:对氧化应激抑制和TXNIP/NLRP3信号通路阻断的机制性见解
Exp Ther Med. 2024 May 9;28(1):277. doi: 10.3892/etm.2024.12565. eCollection 2024 Jul.
肠道微生物与肠-脑轴中NLRP3炎性小体之间的相互作用。
Comput Struct Biotechnol J. 2023 Mar 25;21:2215-2227. doi: 10.1016/j.csbj.2023.03.017. eCollection 2023.
4
Inhibition of the pyroptosis-associated inflammasome pathway: The important potential mechanism of ginsenosides in ameliorating diabetes and its complications.抑制焦亡相关炎性小体通路:人参皂苷改善糖尿病及其并发症的重要潜在机制。
Eur J Med Chem. 2023 May 5;253:115336. doi: 10.1016/j.ejmech.2023.115336. Epub 2023 Apr 5.
5
MicroRNAs in inflammasomopathies.炎症小体病中的微小RNA
Immunol Lett. 2023 Apr-May;256-257:48-54. doi: 10.1016/j.imlet.2023.04.001. Epub 2023 Apr 5.
6
Role of the inflammasome in insulin resistance and type 2 diabetes mellitus.炎症小体在胰岛素抵抗和 2 型糖尿病中的作用。
Front Immunol. 2023 Mar 13;14:1052756. doi: 10.3389/fimmu.2023.1052756. eCollection 2023.
7
Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review).NLRP3 炎性小体通路抑制剂作为炎症性疾病有希望的治疗候选物(综述)。
Int J Mol Med. 2023 Apr;51(4). doi: 10.3892/ijmm.2023.5238. Epub 2023 Mar 24.
8
The interaction between ferroptosis and inflammatory signaling pathways.铁死亡与炎症信号通路的相互作用。
Cell Death Dis. 2023 Mar 21;14(3):205. doi: 10.1038/s41419-023-05716-0.
9
NLRP3 inflammasome activation, metabolic danger signals, and protein binding partners.NLRP3炎性小体激活、代谢危险信号与蛋白质结合伴侣
J Endocrinol. 2023 Mar 30;257(2). doi: 10.1530/JOE-22-0184. Print 2023 May 1.
10
The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors.NLRP3 炎性小体激活的机制及其药理学抑制剂。
Front Immunol. 2023 Jan 18;13:1109938. doi: 10.3389/fimmu.2022.1109938. eCollection 2022.